Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma

Kathryn M. Field, Madeleine T. King, John Simes, David Espinoza, Elizabeth H. Barnes, Kate Sawkins, Mark A. Rosenthal, Lawrence Cher, Elizabeth Hovey, Helen Wheeler, Anna K. Nowak

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma'. Together they form a unique fingerprint.

    Medicine & Life Sciences